AFP and hepatocellular carcinoma: Bonekamp et al. [19] reported that volumetric functional (vADC and volumetric enhancement) response 3-4w after TACE in patients with HCC showed improved overall survival and was superior to current imaging response criteria (RECIST, mRECIST, and EASL) and AFP [19].